Dr. Ben Palanca, MD
Claim this profileWashington University School of Medicine/Barnes-Jewish Hospital
Affiliated Hospitals
Washington University School Of Medicine/Barnes-Jewish Hospital
Washington University School Of Medicine
Clinical Trials Ben Palanca, MD is currently running
Dexmedetomidine
for Delirium
This is a pragmatic phase III, randomized, blinded, double placebo-controlled, three-arm trial of elderly patients following cardiac surgery to assess the relationship between nighttime intravenous (IV) and sublingual dexmedetomidine on postoperative delirium and functional outcomes after surgery.
Recruiting
1 award
Phase 3
Propofol + Therapy
for Depression
The investigators hypothesize that brief behavioral therapy and targeted propofol infusion in depressed geriatric patients will augment subsequent slow wave sleep and improve clinical and cognitive outcomes. The team will recruit 70 participants for a double-blinded placebo controlled randomized controlled trial. Two propofol infusions, 2-6 days apart, will be administered, targeting either a low propofol dose arm (minimal EEG slow waves, brain effect-site concentration 1-2 mcg/ml) or moderate dose propofol arm (maximal induction of EEG slow waves, brain effect site concentration of \>2.5 mcg/ml). The pharmacologic intervention will be paired with 3-4 sessions of Brief Behavioral Therapy for Insomnia for all participants. To minimize bias, there will be no specific gender or ethnic background consideration for enrollment. This will be a single site investigation at Washington University Medical Center.
Recruiting
1 award
Phase 2
2 criteria
More about Ben Palanca, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ben Palanca, MD has experience with
- Propofol
- Dexmedetomidine
- Placebo
Breakdown of trials Ben Palanca, MD has run
Delirium
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ben Palanca, MD specialize in?
Ben Palanca, MD focuses on Depression and Delirium. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Ben Palanca, MD currently recruiting for clinical trials?
Yes, Ben Palanca, MD is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Ben Palanca, MD has studied deeply?
Yes, Ben Palanca, MD has studied treatments such as Propofol, Dexmedetomidine, Placebo.
What is the best way to schedule an appointment with Ben Palanca, MD?
Apply for one of the trials that Ben Palanca, MD is conducting.
What is the office address of Ben Palanca, MD?
The office of Ben Palanca, MD is located at: Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine/Barnes-Jewish Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.